Paul Kelly

Paul Kelly started their work experience in 2009 as a Founding Partner at OneVentures, where they are currently still employed. In 2018, they became a Board Member at Blade Therapeutics Pty Ltd and a Non Executive Director at BiVACOR Inc. In 2017, they took on the role of NonExecutive Director at PROTA THERAPEUTICS PTY LTD. Paul also served as a Member of the Board of Directors at Garvan Institute of Medical Research since 2016. Since 2011, they have been the Chairman of Vaxxas Pty Ltd, and since 2010, they have been the Chairman of Hatchtech Pty Ltd. Prior to that, Paul worked as an Endocrinologist at St Vincents Hospital, Sydney, starting in 2010. Paul also had a role as a Non Executive Director at Clinical Genomics from 2016 to 2021. From 2014 to 2020, they served as a NonExecutive Director at AgaMatrix.

Paul Kelly completed their education at the following institutions:

- From 1978 to 1983, they attended UNSW, where they obtained a Bachelor of Medicine, Bachelor of Surgery (MB BS) with Honors. Their field of study was Medicine.

- Subsequently, from 1987 to 1989, Paul pursued a Master of Medicine (MD) at UNSW, focusing on Genetic Epidemiology, Osteoporosis, and Twin Studies.

- After completing their MD, from 1989 onwards, they enrolled at the Royal Australasian College of Physicians to specialize in Endocrinology. Paul obtained the Fellowship of the Royal Australasian College of Physicians (FRACP).

No additional information is available regarding Paul's education beyond their enrollment at the Royal Australasian College of Physicians.